iShares U.S. Pharmaceuticals ETF: Favorable Long-Term Growth Outlook Should Drive Future Price Appreciation

|
About: iShares U.S. Pharmaceuticals ETF (IHE), Includes: AGN, BMY, ELAN, JAZZ, JNJ, LLY, MRK, MYL, PFE, ZTS
by: Ploutos Investing
This article is exclusive for subscribers.
Ploutos Investing
Dividend growth investing, growth at reasonable price, value, long-term horizon
Summary

Stocks in IHE’s portfolio should benefit from rising global medicine demand.

Most of its top 10 holdings are moaty stocks with competitive position over their peers.

IHE pays a 1.4%-yielding dividend.

ETF Overview

iShares U.S. Pharmaceuticals ETF (IHE) owns a portfolio of large-cap pharmaceutical stocks. The ETF tracks the investment results of the Dow Jones U.S. Select Pharmaceuticals Index. Stocks in IHE's portfolio are